CRISP-3 Antibody (295208) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # FAB23972B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Intracellular Staining by Flow Cytometry
Label
Biotin
Antibody Source
Monoclonal Mouse IgG2B Clone # 295208
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human CRISP-3
Asn21-Tyr245 (Ser106Pro & Ala134Ser)
Accession # P54108.1
Asn21-Tyr245 (Ser106Pro & Ala134Ser)
Accession # P54108.1
Specificity
Detects human CRISP-3 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human CRISP-2 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for CRISP-3 Antibody (295208) [Biotin]
Application
Recommended Usage
Intracellular Staining by Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CRISP-3
Long Name
Cysteine-rich Secretory Protein 3
Alternate Names
Aeg2, CRISP3, SGP28
Gene Symbol
CRISP3
Additional CRISP-3 Products
Product Documents for CRISP-3 Antibody (295208) [Biotin]
Product Specific Notices for CRISP-3 Antibody (295208) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...